# REGADENOSON
> **ANDA214349** · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 2022-08-31
## Drug
- **FDA Application Number:** ANDA214349
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** REGADENOSON
- **Generic name:** REGADENOSON
- **Active ingredients:** REGADENOSON
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HOSPIRA
- **Manufacturer:** Hospira, Inc.
- **First approval:** 2022-08-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214349)
---
*AI Analytics · CC0 1.0*